UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Care pathways in atopic dermatitis: a retrospective population‐based cohort study

Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.1456-1466

2022

Volltextzugriff (PDF)

AB0100 Identification of the antimicrobial peptide LL-37 as a potential mediator of synovial inflammation in RA

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.643-643

2013

Volltextzugriff (PDF)

SAT0120 Anti TNF therapy with adalimumab restores the bone metabolism balance through a dual mechanism in rheumatoid arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.511-511

2013

Volltextzugriff (PDF)

Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis

Scandinavian journal of rheumatology, 2014-03, Vol.43 (2), p.85-90

2014

Volltextzugriff (PDF)

SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.831

2017

Volltextzugriff (PDF)

Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany: A Real-World Preliminary Analysis

Value in health, 2017-10, Vol.20 (9), p.A565-A566

2017

Volltextzugriff (PDF)

PSY120 - Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany: A Real-World Preliminary Analysis

Value in health, 2017-10, Vol.20 (9), p.A565-A566

2017

Volltextzugriff (PDF)

Methothrexate directly inhibits RANKL expression and osteoclast formation in very early arthritis

ANNALS OF THE RHEUMATIC DISEASES, 2010-03, Vol.69 (Suppl 2), p.A23-A23

2010

Volltextzugriff (PDF)

Comorbidities in childhood atopic dermatitis: A population‐based study

Journal of the European Academy of Dermatology and Venereology, 2024-02, Vol.38 (2), p.354-364

2024

Volltextzugriff (PDF)

The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats

Annals of the rheumatic diseases, 2013-07, Vol.72 (7), p.1239-1248

2013

Volltextzugriff (PDF)

Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate

Arthritis research & therapy, 2013-01, Vol.15 (6), p.R205-R205, Article R205

2013

Volltextzugriff (PDF)

Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases

Dermatology and therapy, 2022-02, Vol.12 (2), p.545-559

2022

Volltextzugriff (PDF)

Direct healthcare cost of atopic dermatitis in the Swedish population

Journal of investigative dermatology, 2021, Vol.141 (5 Suppl.), p.S45

2021

Volltextzugriff (PDF)

250 Direct healthcare cost of atopic dermatitis in the Swedish population

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S45

2021

Volltextzugriff (PDF)

LL-37 is expressed in the inflamed synovium in patients with rheumatoid arthritis and downregulated by TNF inhibitors

ANNALS OF THE RHEUMATIC DISEASES, 2012-02, Vol.71 (Suppl 1), p.A12-A12

2012

Volltextzugriff (PDF)

Childbearing and the Risk of Scleroderma: A Population-based Study in Sweden

American journal of epidemiology, 2004-01, Vol.159 (2), p.162-166

2004

Volltextzugriff (PDF)

Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis

Arthritis research & therapy, 2008-01, Vol.10 (6), p.R147-R147, Article R147

2008

Volltextzugriff (PDF)

Patient Characteristics Associated with Discontinuation of Tofacitinib for the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years

ARTHRITIS & RHEUMATOLOGY, 2018, Vol.70

2018

Volltextzugriff (PDF)

Anti-TNF therapy with adalimumab restores the bone metabolism balance through a dual mechanism in rheumatoid arthritis

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, Vol.43, p.57

2014

Volltextzugriff (PDF)

ANTI TNF THERAPY WITH ADALIMUMAB RESTORES THE BONE METABOLISM BALANCE THROUGH A DUAL MECHANISM IN RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES, 2013, Vol.71, p.511

2013

Volltextzugriff (PDF)

Evaluation of arthroscopy and macroscopic scoring

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, Vol.35, p.54

2006

Volltextzugriff (PDF)

Identification of the Antimicrobial Peptide LL-37 As a Potential Mediator of Synovial Inflammation in Rheumatoid Arthritis

ARTHRITIS AND RHEUMATISM, 2012, Vol.64 (10), p.S764

2012

Volltextzugriff (PDF)

Growth and endocrine effects of recombinant bovine growth hormone treatment in non-transgenic and growth hormone transgenic coho salmon

General and comparative endocrinology, 2012-05, Vol.177 (1), p.143-152

2012

Volltextzugriff (PDF)

Comorbidity burden in adult atopic dermatitis: A population‐based study

JEADV clinical practice, 2024-03, Vol.3 (1), p.128-141

2024

Volltextzugriff (PDF)

Societal economic burden and determinants of costs for atopic dermatitis

JEADV clinical practice, 2022-12, Vol.1 (4), p.326-343

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(21)
Tagungsberichte
(5)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Care pathways in atopic dermatitis: a retrospective population‐based cohort study

AB0100 Identification of the antimicrobial peptide LL-37 as a potential mediator of synovial inflammation in RA

SAT0120 Anti TNF therapy with adalimumab restores the bone metabolism balance through a dual mechanism in rheumatoid arthritis

Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis

SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry

Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany: A Real-World Preliminary Analysis

PSY120 - Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany: A Real-World Preliminary Analysis

Methothrexate directly inhibits RANKL expression and osteoclast formation in very early arthritis

Comorbidities in childhood atopic dermatitis: A population‐based study

The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats

Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate

Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases

Direct healthcare cost of atopic dermatitis in the Swedish population

250 Direct healthcare cost of atopic dermatitis in the Swedish population

LL-37 is expressed in the inflamed synovium in patients with rheumatoid arthritis and downregulated by TNF inhibitors

Childbearing and the Risk of Scleroderma: A Population-based Study in Sweden

Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis

Patient Characteristics Associated with Discontinuation of Tofacitinib for the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years

Anti-TNF therapy with adalimumab restores the bone metabolism balance through a dual mechanism in rheumatoid arthritis

ANTI TNF THERAPY WITH ADALIMUMAB RESTORES THE BONE METABOLISM BALANCE THROUGH A DUAL MECHANISM IN RHEUMATOID ARTHRITIS

Evaluation of arthroscopy and macroscopic scoring

Identification of the Antimicrobial Peptide LL-37 As a Potential Mediator of Synovial Inflammation in Rheumatoid Arthritis

Growth and endocrine effects of recombinant bovine growth hormone treatment in non-transgenic and growth hormone transgenic coho salmon

Comorbidity burden in adult atopic dermatitis: A population‐based study

Societal economic burden and determinants of costs for atopic dermatitis

Suchergebnisse filtern